Literature DB >> 7979606

Biological therapy of sepsis.

J A Norton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7979606      PMCID： PMC1234446          DOI： 10.1097/00000658-199411000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  11 in total

1.  Monoclonal antibody to TNF in severe septic shock.

Authors:  A R Exley; J Cohen; W Buurman; R Owen; G Hanson; J Lumley; J M Aulakh; M Bodmer; A Riddell; S Stephens
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

Review 2.  Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy.

Authors:  J E Parrillo; M M Parker; C Natanson; A F Suffredini; R L Danner; R E Cunnion; F P Ognibene
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

3.  Protective antibody to endotoxin core: the emperor's new clothes?

Authors:  E J Ziegler
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

4.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

5.  Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients.

Authors:  T J Babineau; P Marcello; W Swails; A Kenler; B Bistrian; R A Forse
Journal:  Ann Surg       Date:  1994-11       Impact factor: 12.969

Review 6.  Biology of interleukin 1.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1988-02       Impact factor: 5.191

7.  A randomized, prospective trial of postoperative somatostatin analogue in patients with neuroendocrine tumors of the pancreas.

Authors:  J R Lange; S M Steinberg; G M Doherty; H N Langstein; D E White; T H Shawker; R C Eastman; R T Jensen; J A Norton
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

8.  Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group.

Authors:  E J Ziegler; C J Fisher; C L Sprung; R C Straube; J C Sadoff; G E Foulke; C H Wortel; M P Fink; R P Dellinger; N N Teng
Journal:  N Engl J Med       Date:  1991-02-14       Impact factor: 91.245

9.  Role of octreotide in the prevention of postoperative complications following pancreatic resection.

Authors:  M Büchler; H Friess; I Klempa; P Hermanek; U Sulkowski; H Becker; A Schafmayer; I Baca; D Lorenz; R Meister
Journal:  Am J Surg       Date:  1992-01       Impact factor: 2.565

10.  A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice.

Authors:  H R Alexander; G M Doherty; C M Buresh; D J Venzon; J A Norton
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.